Episode Details
Back to Episodes
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
Published 7 years, 3 months ago
Description
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?